GSK Remains Open To Consumer Healthcare Sale As It Prepares To Name CEO
Responding directly to a call from an activist investor to consider selling Consumer Healthcare, GSK says it will evaluate any acquisition proposals it receives. A six-month long process to appoint a CEO to lead the new standalone OTC business is also nearing its conclusion.
You may also be interested in...
GSK has secured strong retail experience for its new standalone Consumer Healthcare business with the appointment of ex-Tesco boss Sir Dave Lewis.
Following a six month selection process, GSK has named Brian McNamara as CEO designate of its standalone Consumer Healthcare business, which will list on the London Stock Exchange next year.
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt are all hoping for a sales boost in Q2 following a difficult Q1 due to the almost non-existent cough and cold season. This earnings preview highlights what to look out for as these four firms report their second-quarter results over the coming weeks.